Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China

References

• Reiffel JA. Atrial fibrillation and stroke: epidemiology. Am J Med 2014;127:e15-e16
   Web of Science ®Google Scholar
• Guo Y, Tian Y, Wang H, et al. Prevalence, incidence, and lifetime risk of atrial fibrillation in China. Chest 2015;147:109-19
   PubMed Web of Science ®Google Scholar
• Lip GYH, Lane DA. Stroke prevention in atrial fibrillation. JAMA 2015;313:1950
   PubMed Web of Science ®Google Scholar
• Bassand J-P. Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents. Europace 2012;14:312-24
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 2014;64:2245-80
   Web of Science ®Google Scholar
• Raparelli V, Proietti M, Cangemi R, et al. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Thromb Haemost 2016;117:209-18
   PubMed Web of Science ®Google Scholar
• Simons LA, Ortiz M, Freedman SB, et al. Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience. Curr Med Res Opin 2016;32:1857-61
   PubMed Web of Science ®Google Scholar
• Patel SI, Cherington C, Scherber R, et al. Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy. J Am Osteopath Assoc 2017;117:7-15
   PubMed Web of Science ®Google Scholar
• Suzuki T, Shiga T, Omori H, et al. Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. J Cardiol 2017;70:238–43. doi:10.1016/j.jjcc.2016.11.009
   PubMed Web of Science ®Google Scholar
• Buck J, Kaboli P, Gage BF, et al. Trends in antithrombotic therapy for atrial fibrillation: data from the Veterans Health Administration Health System. Am Heart J 2016;179:186-91
   PubMed Web of Science ®Google Scholar
• Yang X, Li Z, Zhao X, et al. Use of warfarin at discharge among acute ischemic stroke patients with nonvalvular atrial fibrillation in China. Stroke 2016;47:464-70
   PubMed Web of Science ®Google Scholar
• Wang Z-Z, Du X, Wang W, et al. Long-term persistence of newly initiated warfarin therapy in Chinese patients with nonvalvular atrial fibrillation. Circ Cardiovasc Qual Outcomes 2016;9:380-7
   PubMed Web of Science ®Google Scholar
• Wu Y, Yang C, Xi H, et al. Prescription of antibacterial agents for acute upper respiratory tract infections in Beijing, 2010–2012. Eur J Clin Pharmacol Berlin/Heidelberg 2016;72:359-64
   PubMed Web of Science ®Google Scholar
• Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 2010;137:263-72
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 2010;138:1093-100
   PubMed Web of Science ®Google Scholar
• Gao Q, Fu X, Wei JW, et al. Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (quality evaluation of stroke care and treatment) registry study. Int J Stroke 2013;8:150-4
   PubMed Web of Science ®Google Scholar
• Lin S, Wu B, Hao Z-L, et al. Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis 2011;31:419-26
   PubMed Web of Science ®Google Scholar
• Chang S-S, Dong J-Z, Ma C-S, et al. Current status and time trends of oral anticoagulation use among Chinese patients with nonvalvular atrial fibrillation. Stroke 2016;47:1803-10
   PubMed Web of Science ®Google Scholar
• Du X, Ma C, Wu J, et al. Rationale and design of the Chinese atrial fibrillation registry study. BMC Cardiovasc Disord 2016;16:130
   PubMed Web of Science ®Google Scholar
• Mochalina N, Joud A, Carlsson M, et al. Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: a population-based cohort study. Thromb Res 2016;140:94-9
   PubMed Web of Science ®Google Scholar
• Niu J-W, Yuan J, Gao S, et al. Low awareness of stroke guidelines and preference for Chinese herbs in community physicians: a national survey in China. Ann Transl Med 2014;2:76
   PubMedGoogle Scholar
• Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 2013;35:312-19
   PubMed Web of Science ®Google Scholar
• Zeitler EP, Eapen ZJ. Anticoagulation in heart failure: a review. J Atr Fibrillation 2015;8:31-8
   PubMedGoogle Scholar
• Romley JA, Gong C, Jena AB, et al. Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis. BMJ 2015;351:h6223
   PubMed Web of Science ®Google Scholar
• Nutescu E, Chuatrisorn I, Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 2011;31:326-43
   PubMed Web of Science ®Google Scholar
• Cotté F-E, Chaize G, Kachaner I, et al. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France. J Stroke Cerebrovasc Dis 2014;23:e73-e83
   PubMed Web of Science ®Google Scholar
• Yao X, Abraham NS, Alexander GC, et al. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc 2016;5:e003074
   PubMed Web of Science ®Google Scholar
• Takabayashi K, Hamatani Y, Yamashita Y, et al. Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation. Stroke 2015;46:3354-61
   PubMed Web of Science ®Google Scholar
• Yang Y-M, Shao X-H, Zhu J, et al. Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis. Int J Cardiol 2014;173:242-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Kong MC, Ko Y. Comparison of three medication adherence measures in patients taking warfarin. J Thromb Thrombolysis 2013;36:416-21
   PubMed Web of Science ®Google Scholar
• Liu F-D, Zhao R, Wang X-M, et al. Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai. Chronic Dis. Transl. Med. [Internet]. 2015;1:203-209. Available from: http://www.sciencedirect.com/science/article/pii/S2095882X15000717.
   PubMedGoogle Scholar